Amyloid beta: structure, biology and structure-based therapeutic development
By Guoqiang Chen, Ting-Hai Xu, Yan Yan, Yu-ren Zhou, Yi Jiang, K. Melcher, H. Xu. Acta Pharmacologica Sinica, 2017
1,651 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Pharmacology, Physiology
View Paper: https://www.semanticscholar.org/paper/7a4ca938fc460c8157f3a1a239a1792e731096ba
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
Citations in the corpus
- Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies (2024, background): “78,111,112 115 However, FAD mutations are not necessarily linked to an increase in A β 42 levels or an elevation of A β 42 /A β 40 ratio.”
- Brain-Gut-Microbiota Axis in Alzheimer’s Disease (2019, background): “In normal conditions soluble Aβ is transported from the blood to the brain via RAGE and via low-density lipoprotein receptor-related protein 1 in the opposite direction.(12,75)”